CVNA Archives - Page 6 of 7 - Blue Horseshoe Stocks

Huge Day for Fresh Options Plays

Thursday’s Options Clean Sweep:

Our 2022 has started off with a bang just a couple of weeks into it, in which the vast majority of the options plays we’ve signaled interest in have produced excellent results.

Yesterday was no exception to that, with all three of our designated targets yielding the opportunity to log multibag intraday gains. We were after the KBH Weekly $44-46 Calls, the TSM Weekly $136-139 Calls, and the DAL Weekly $40-42 Calls, and despite a rather poor day for the markets as a whole each one of these bullish ideas made a bullish move on the day.

Here are the daily ranges and total possible single session profits that were there for the taking:

KBH Weekly $44-46 Calls
$44: 2.10-6.00 (+186%)
$45: 1.55-5.00 (+223%)
$46: 1.00-4.00 (+300%)
_____

TSM Weekly $136-139 Calls
$136: 3.80-9.05 (+138%)
$137: 3.75-8.10 (+116%)
$138: 3.52-7.20 (+105%)
$139: 2.52-6.40 (+154%)
_____

DAL Weekly $40-42 Calls
$40: 1.25-2.70 (+116%)
$41: .73-1.85 (+153%)
$42: .38-1.18 (+211%)

Fresh Options Ideas:

We’ve also got a wide range of both short and long term options ideas to the short and long sides to track this morning. Some are earnings related, and others merely have technical setups we find interesting.

CVNA 03/04 $190-200 Calls
AMC Weekly $21-20 Puts
WFC Weekly $55-56 Calls
JPM Weekly $165-162.50 Puts
SPY 01/14 $462.50-461 Puts

Extended Watchlist:
CYDY, HMBL, DRFS, RMSL, CBGL, GOFF, REVB, NXTP, SSXC

Finishing Out the Trading Week with a Bang

Options Blowout Continues:

In yesterday morning ‘s premarket report, two of our three sets of fresh options ideas were bearish in nature, and despite the markets going on a tear for the session, it was those puts that fared the best.

We’re talking about the CI Weekly $225 Puts, and the ROKU Weekly $395-390 Puts, both of which recorded multi-bag intraday runs on the day. Those figures were as follows:

CI Weekly $225 Puts
$45: 9.50-24.50 (+158%)
_____

ROKU Weekly $395-390 Puts
$395: 4.31-10.02 (+132%)
$392.50: 3.73-8.12 (+118%)
$390: 2.92-7.30 (+150%)

Moderna, Inc. MRNA – Update:

We also wanted to swing back around to provide an update on the MRNA Calls that we initially began tracking on June 21st, the MRNA 08/20 $195-210 Calls. The stock itself has exploded over that time period, from a low of 200.00 the day of our first alert, to yesterday’s new high of 443.99, a move of 122% That move has facilitated these amazing gains in our designated options plays:

MRNA 08/20 $195-210 Calls
$195: 23.50-222.50 (+847%)
$200: 18.00-241.10 (+1239%)
$210: 13.55-214.50 (+1483%)

eXp World Holdings Inc. EXPI – Update:

We’ve also been following another set of longer term calls, the EXPI 08/20 $40-45 Call, which continue to pile on the new highs for us.

EXPI 08/20 $40-45 Calls
$40: 1.55-10.00 (+545%)
$45: 1.30-5.70 (+338%)

These gains were made possible in part by the buzz caused by the company’s blockbuster earnings report and first-ever cash dividends. We will look to roll up our strike area to include the $50 Calls as well, with EXPI appearing ready to continue its impressive upward trajectory.

Fresh Options Ideas:
DKNG Weekly $53.50-55.50 Calls*
CVNA Weekly $355-370 Calls*

*Beginning-to-intermediate level traders should not attempt to trade options on their day of expiration

Extended Watchlist:
KXIN, ANY, BEST, MVST, TSOI, RGBP, TXTM, ASTI, EEGI, NWBO, ICOA, JOEY

Big OTC Winners

ADM Endeavors Inc. ADMQ
–
We are back once again this morning to provide yet another update on ADMQ, the hot play that we began tracking last month, beginning with the Special Report we put out on July 22nd. Subsequent to that report, the stock was trading for as little as .032 per share.

For the second straight day yesterday, ADMQ was pushed to new highs, reaching .0793. That brings our total witnessed range on this play to a very respectable 148% over the course of just a couple weeks.

Once again today, the company has released some important news that we wanted to pass along to our readers:

Dallas, TX – (NewMediaWire) – August 07, 2020 – ADM Endeavors, Inc. (OTCQB: ADMQ) is pleased to announce that its wholly owned subsidiary, Just Right Products, Inc., has entered into a commercial construction agreement with Sullins Construction Corp. of Fort Worth, Texas, to build the Company’s new 70,000 square foot production facility located in Fort Worth.

Marc Johnson, CEO of ADM Endeavors, stated that the construction will commence in early fall 2020, dependent on the City of Fort Worth permitting timelines. Cost of the Company’s expansion from a current operational space of 18,000 square-foot to a new 70,000 square-foot production facility is estimated at $5 million and is projected to be completed in the first quarter of 2021. (>>Read Full PR)

_____

Interested in More Information on ADMQ?
Please visit ADMEndeavors.com
or contact Peter Nicosia at (585)703-6565

Relief Therapeutics Holdings RLFTF
‘
We also had signaled interest for RLFTF in yesterday’s premarket report, via the Extended Watchlist, and we’d like to talk about the performance in that play as well. It was the talk of the OTC yesterday, and we were on it like white on rice!

The stock traded up from a low of .35 and went on to register its new high of .95. That works out to a single session gain of 161% and it would appear as if that figure may be raised today.

Fresh Options Ideas:
AAPL Weekly $450-455 Calls
CVNA Weekly $215-220 Calls
TMUS Weekly $111-113 Calls

Blue Horseshoe Stocks: Huge Options Wins

Cronos Group, Inc. CRON – Recap

We’ve been tracking CRON heavily this week, after having observed its swing low of 6.50 last week, the stock has now strung together seven consecutive bullish sessions, and yesterday attained a new high of 9.95, marking a 53% increase in roughly a week.

CRON Weekly $8 & $8.50 Calls were initially targeted in our report from Tuesday morning, and those attained new highs. We’ve now seen a move from the $8 Calls from .50-1.85 for a gain of 270%, and the $8.50’s updated range runs from .30 to 1.40, a gain of 367% in just two sessions’ time.

Yesterday we mentioned that we’d also look to roll up to higher strike points with the $9 & $9.50 Calls and those produced huge gain opportunities on the day. The $9’s moved up from a low of .20 and went on to hit a dollar, for a 400% rip, while the $9.50’s took the cake with a mega run from .10 to 70, a 600% gain.

CRON looks to be gearing down a bit this morning, but at this point it owes us nothing, and was a really great midweek play for us on the options front.

CVS Health Corp. CVS – Update

We also targeted some CVS calls on Tuesday– the CVS Weekly $75 & $75.50 Calls and did very well with those right out of the gate. We have some new highs there as well thanks to a solid session yesterday.

So far we’ve seen the $75 Calls trade from 1.05 to their new high at 6.00 (+471%), while the $75.50’s have run from .84-5.00 for gains of up to 495%, continuing our stellar week of fantastic options calls.

We also provided a pair of fresh options ideas in yesterday’s report, and kept the multi-bag profit train rolling with both targets:

ETSY Weekly $45 Calls
Range: 2.40-6.70 – Max Gain: 179%

TWLO Weekly $80-82 Calls
$80 – 3.15-16.37 (+420%)
$80.50 – 2.70-7.02 (+160%)
$81 – 2.33-14.80 (+535%)
$81.50 – 2.70-10.89 (+303%)
$82 – 2.25-13.80 (+513%)

Extended Watchlist:
ANGI, ARRS, AVLR, CVNA, CYBR, SESN, SND,

Blue Horseshoe Stocks: Z Follow-Up & More

Zillow Group, Inc. Z

First thing’s first- we wanted to update our readers once again on the Zillow calls we made on Tuesday morning. We designated the Z Weekly $48-49 Calls as our targets and after a good first day, the stock continued its upward climb during yesterday’s session.

That move alloted for even further increases on our observed range of contracts, and pushed our two-day observed swings well into multi-bag territory:

$48 Calls – Range: 1.30-3.55 – Max Gain: 173%
$48.50 Calls – Range: 1.10-2.60 – Max Gain: 136%
$49 Calls – Range: .80-2.60 – Max Gain: 225%
________

Fresh Ideas:
YELP Weekly $43-44.50 Calls
ROKU Weekly $52-53.50 Calls

Healthmed Services, Inc HEME

It isn’t often these days that we target a subpenny OTC stock. Our long-time followers know that those were our primary focus when we started out exactly 7 years ago this past Tuesday. We did very well in that capacity for many years, despite having recently shifted focus more to fast-paced options trading.

Of any of the sectors we ever covered in the OTC space, cannabis has certainly been the most exciting, and continues to be one of our primary interests on the stock side of things to this day.

That’s why we just want to put HEME on our readers radars. Despite being listed as defunct on OTC Markets, the company recently revealed its intentions to get things back on track and enter the marijuana space.

According to its updated website, HEME is presently acquiring, leasing and licensing growers for the cultivation, production and distribution of cannabis and cannabis-related products in southern California. The project site has state Highway access, water and local transportation are convenient and accessible, and the City government has designated the project site – legal planting zoning.

We are going to keep tabs on the company’s progress toward not only developing in this new direction, but also coming current on its reporting.

Extended Watchlist:
WIN, UPL, TIVO, ANGI, CVNA, RDHL,